Annual Cash & Cash Equivalents
$4.58B$291.85M-5.99%
Summary
- Current Value
- As of today, GSK annual cash & cash equivalents is $4.58B, down -5.99% on
- Historical Performance
- GSK annual cash & cash equivalents is down -51.65% over the past 3 years, down -47.39% over the past 5 years
- All-Time High Comparison
- GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on
- 3-Year Low Comparison
- GSK annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- GSK annual cash & cash equivalents is higher than 97.59% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $4.58B | -6.0% | -51.6% | -47.4% | -53.8% | |
| Quarterly Cash & Cash Equivalents | $4.54B | -21.6% | -47.4% | -31.7% | -58.0% | |
| Price | $49.00 | +17.6% | +43.6% | +25.2% | +14.0% | |
| Annual Current Assets | $23.55B | +10.6% | -5.7% | -14.9% | -6.2% | |
| Annual Total Liabilities | $60.75B | +4.6% | +0.9% | -25.5% | +19.4% | |
| Annual Working Capital | -$5.22B | +11.3% | -112.6% | -100.9% | -202.8% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.48B | N/A | -51.6% |
| 5Y | $9.48B | -51.6% | |
| All | $11.21B | -59.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.58B | at low | |
| 5Y | $4.58B | at low | |
| All | $37.03M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of GSK?
As of today, GSK annual cash & cash equivalents is $4.58B
What is 1-year change in GSK annual cash & cash equivalents?
GSK annual cash & cash equivalents is down -5.99% year-over-year
What is 3-year change in GSK annual cash & cash equivalents?
GSK annual cash & cash equivalents is down -51.65% over the past 3 years
How far is GSK annual cash & cash equivalents from its all-time high?
GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on December 31, 2009
How does GSK annual cash & cash equivalents rank versus sector peers?
GSK annual cash & cash equivalents is higher than 97.59% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$4.54B$40.96M-0.89%
Summary
- Current Value
- As of today, GSK quarterly cash & cash equivalents is $4.54B, down -0.89% on
- Historical Performance
- GSK quarterly cash & cash equivalents is down -21.57% year-over-year, down -47.35% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash & cash equivalents is currently -70.77% below its historical high of $15.54B set on
- 3-Year Low Comparison
- GSK quarterly cash & cash equivalents is +20.41% above its 3-year low of $3.77B reached on
- Sector Comparison
- GSK quarterly cash & cash equivalents is higher than 97.57% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $4.54B | -0.9% | -21.6% | -47.4% | -31.7% | |
| Annual Cash & Cash Equivalents | $4.58B | – | -6.0% | -51.6% | -47.4% | |
| Price | $49.00 | -15.9% | +17.6% | +43.6% | +25.2% | |
| Quarterly Current Assets | $23.42B | -0.6% | +0.3% | -3.9% | -8.4% | |
| Quarterly Total Liabilities | $59.93B | -1.3% | -1.3% | +2.5% | -23.9% | |
| Quarterly Working Capital | -$6.16B | -17.9% | -73.7% | -409.6% | -154.8% | |
| Quarterly Net Income | $2.48B | +156.3% | +11.0% | +25.0% | +42.6% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.79B | N/A | -21.6% |
| 3Y | $8.62B | N/A | -47.4% |
| 5Y | $10.37B | -56.2% | |
| All | $15.54B | -70.8% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.45B | +2.0% | |
| 3Y | $3.77B | +20.4% | |
| 5Y | $3.77B | +20.4% | |
| All | $37.03M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of GSK?
As of today, GSK quarterly cash & cash equivalents is $4.54B
What is GSK quarterly cash & cash equivalents most recent change?
GSK quarterly cash & cash equivalents was down -0.89% on March 31, 2026
What is 1-year change in GSK quarterly cash & cash equivalents?
GSK quarterly cash & cash equivalents is down -21.57% year-over-year
How far is GSK quarterly cash & cash equivalents from its all-time high?
GSK quarterly cash & cash equivalents is currently -70.77% below its historical high of $15.54B set on March 31, 2015
How does GSK quarterly cash & cash equivalents rank versus sector peers?
GSK quarterly cash & cash equivalents is higher than 97.57% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk